申请人:Player R. Mark
公开号:US20050004112A1
公开(公告)日:2005-01-06
The invention is directed to compounds of Formulae I, II and III:
wherein A, R
1
, R
2
, R
3
, R
4
, X, Y and W are set forth in the specification, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase.
本发明涉及式I、II和III的化合物:其中A、R1、R2、R3、R4、X、Y和W在说明书中列出,以及其溶剂化物、水合物、互变异构体或药学上可接受的盐,其抑制蛋白酪氨酸激酶,特别是c-fms激酶。